Skip to content
Public Health Communication Collaborative

Select list(s) to subscribe to

By submitting this form, you are consenting to receive marketing emails from: Public Health Communications Collaborative, https://publichealthcollaborative.org/. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Communications ResourcesFor Public Health Officials
MENUMENU
  • Messaging Resources
  • Tough Questions
  • Misinformation
  • Webinars
  • Topics
    • Children and COVID-19
      • Pediatric vaccines
      • Schools and in-person learning
      Emergent Public Health Concerns
      • Mpox (Monkeypox)
      • Flu
      • Tripledemic
      Mask Guidance
      • Mask usage
      • When to Wear a Mask
      Quarantine and Isolation
      • COVID-19 exposure or testing positive
      • Travel
      Testing, Tracing, and Treatment
      • Herd Immunity
      • Testing
      • COVID-19 + the flu shot
      • Antiviral drugs
      • Contact notification
      Trust and Uncertainty
      • Pandemic Fatigue
      • Data and reporting
      • Trust
      Vaccines
      • Johnson & Johnson vaccine
      • FDA approval
      • Booster doses
      • Pregnancy and fertility
      • Development, safety, and effectiveness
      • Vaccine mandates
      • Novavax Vaccine
      Variants
      • Omicron
      • New COVID-19 variants
  • About
  • Contact
  • Subscribe
Children and COVID-19
  • Pediatric vaccines
  • Schools and in-person learning
Emergent Public Health Concerns
  • Mpox (Monkeypox)
  • Flu
  • Tripledemic
Mask Guidance
  • Mask usage
  • When to Wear a Mask
Quarantine and Isolation
  • COVID-19 exposure or testing positive
  • Travel
Testing, Tracing, and Treatment
  • Herd Immunity
  • Testing
  • COVID-19 + the flu shot
  • Antiviral drugs
  • Contact notification
Trust and Uncertainty
  • Pandemic Fatigue
  • Data and reporting
  • Trust
Vaccines
  • Johnson & Johnson vaccine
  • FDA approval
  • Booster doses
  • Pregnancy and fertility
  • Development, safety, and effectiveness
  • Vaccine mandates
  • Novavax Vaccine
Variants
  • Omicron
  • New COVID-19 variants
  • About Us
  • Contact Us
  • Privacy Policy
  • Follow
  • Twitter
  • Linkedin

The Public Health Communications Collaborative (PHCC) was formed in 2020 to coordinate and amplify public health messaging on COVID-19 and increase Americans' confidence in guidance from the Centers for Disease Control and Prevention (CDC) and state and local public health officials. See more information, including partners.

Close Menu

Get Updates

Messaging resources, misinformation alerts, webinars, and more—all designed to support you to effectively communicate about public health issues.

Select list(s) to subscribe to

By submitting this form, you are consenting to receive marketing emails from: Public Health Communications Collaborative, 3050 K Street NW, Washington, DC, 20007, https://publichealthcollaborative.org/. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact